Cytokine Signalling Forum

Cours de FMC




« Retour au menu principal

Strategies for Improving Patient Outcomes in Rheumatoid Arthritis

Developed under the auspices of the University of Glasgow supported by an unrestricted educational grant from Pfizer Italia S.r.l.

This course is a 1-hour tutorial that has been designed as an educational resource for qualified rheumatologists of all levels of seniority. The field of rheumatology is constantly evolving in terms of available therapeutic options, and also management strategies which increasingly focus on the importance of a patient-centred approach. As such, it is important to understand how patient reported outcomes can play a role in target-oriented disease management. This course aims to address this by providing an understanding of these evolving management strategies in rheumatoid arthritis, the role of patient reported outcomes in these strategies, and the role of novel targeted small molecule therapies now and in the future.

By following this programme, members of the Cytokine Signalling Forum will be able to:

  • Understand the potential role of small molecule therapies in the management of rheumatoid arthritis
  • Understand the role of the patient perspective in assessing treatment response
  • The importance of patient reported outcomes to determine the impact of cytokine signalling pathway targeted therapies on quality of life
This course has been accredited by the EACCME.
Health Awards spring 2015

Module Présentateur Vidéo Questions
Introduction
Professor Laure Gossec image
Professor Laure Gossec

Professor of Rheumatology,
Université Pierre et Marie Curie and Hôpital Pitié-Salpêtrière, Paris, France

Professor Laure Gossec received her medical and rheumatology specialist degree from Paris University in 2002. She holds a Master's degree and a PhD in clinical epidemiology, obtained in 2008 on the subject of 'composite criteria in rheumatology'. In the clinic in Paris, she is responsible for the day-hospitalisation section where patients are treated with biologics.

Professor Gossec’s research interests include outcome measures in clinical trials, prediction of disease and severity, and the use of biologics in rheumatoid arthritis (RA). She also has expertise in meta-analyses. Professor Gossec has authored or co-authored more than 140 research papers, mainly relating to RA, psoriatic arthritis and spondyloarthritis. She is particularly interested in the patient’s perspective, and was the facilitator of a European League Against Rheumatism (EULAR) initiative developing a patient-derived weighted score to assess the impact of RA, known as the RAID (RA Impact of Disease) score. Professor Gossec is now leading a similar EULAR project in psoriatic arthritis.

Prof. Laure Gossec (Bio)
01:05
Evolving management strategies for rheumatoid arthritis
Professor Juan J. Gómez-Reino image
Professor Juan J. Gómez-Reino

Head of the Department of Rheumatology,
University Hospital, Santiago de Compostela, Spain

Professor Juan Gómez-Reino completed his medical and doctor of philosophy degrees at the University of Madrid, Spain and his postgraduate training in internal medicine and rheumatology at the New York State University, Stony Brook, USA. He was formerly chief of the Department of Research and Section of Rheumatology at Hospital Doce de Octubre, Madrid, Spain.

Professor Gómez-Reino’s main clinical interest is chronic inflammatory arthropathies, and his experimental research is in the genetics of complex diseases, the effect of neuropeptides on chondrocyte function, and arthritis in animal models. He has authored or co-authored a number of original articles and papers in the areas of rheumatoid arthritis, spondyloarthritis and other rheumatology-specific disorders.

Prof. Juan J. Gomez-Reino (Bio)
09:41 7
Patient perspectives in assessing treatment response in rheumatoid arthritis
Professor Laure Gossec image
Professor Laure Gossec

Professor of Rheumatology,
Université Pierre et Marie Curie and Hôpital Pitié-Salpêtrière, Paris, France

Professor Laure Gossec received her medical and rheumatology specialist degree from Paris University in 2002. She holds a Master's degree and a PhD in clinical epidemiology, obtained in 2008 on the subject of 'composite criteria in rheumatology'. In the clinic in Paris, she is responsible for the day-hospitalisation section where patients are treated with biologics.

Professor Gossec’s research interests include outcome measures in clinical trials, prediction of disease and severity, and the use of biologics in rheumatoid arthritis (RA). She also has expertise in meta-analyses. Professor Gossec has authored or co-authored more than 140 research papers, mainly relating to RA, psoriatic arthritis and spondyloarthritis. She is particularly interested in the patient’s perspective, and was the facilitator of a European League Against Rheumatism (EULAR) initiative developing a patient-derived weighted score to assess the impact of RA, known as the RAID (RA Impact of Disease) score. Professor Gossec is now leading a similar EULAR project in psoriatic arthritis.

Prof. Laure Gossec (Bio)
19:00 13
Evaluation 4

Date de préparation: December 2013